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The print version of the article listed above contains a typographical error on page 44, in the sentence "Injections of insulin (or vehicle aCSF), PI3K-I (or vehicle aCSF with 5% DMSO), or insulin antibodies (I8510; Sigma, St. Louis, MO) (or vehicle aCSF) were administered directly to the POA through the POA-implanted cannula (anterior-posterior \[AP\] from bregma = −0.38 mm, lateral \[Lat\] = midline, ventral \[V\] = 3.8 mm, cannula 26 GA, 10 mm length) using an injector (33 GA, protruding 0.4 mm beyond the tip of the cannula, total length 10.4 mm) connected to plastic tubing and a microsyringe (10 μl) in a volume of 0.5 μl over a period of 5 min to allow diffusion (n = 5 mice per group)." The correct sentence should read as follows: "Injections of insulin (or vehicle aCSF), PI3K-I (or vehicle aCSF with 5% DMSO), or insulin antibodies (I8510; Sigma, St. Louis, MO) (or vehicle aCSF) were administered directly to the POA through the POA-implanted cannula (anterior-posterior \[AP\] from bregma = 0.38 mm, lateral \[Lat\] = midline, ventral \[V\] = 3.8 mm, cannula 26 GA, 10 mm length) using an injector (33 GA, protruding 0.4 mm beyond the tip of the cannula, total length 10.4 mm) connected to plastic tubing and a microsyringe (10 μl) in a volume of 0.5 μl over a period of 5 min to allow diffusion (n = 5 mice per group)." The online version reflects these changes.
